Linked Life Data

12230326

Source:http://linkedlifedata.com/resource/pubmed/id/12230326

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12230326rdf:typepubmed:Citationlld:pubmed
pubmed-article:12230326lifeskim:mentionsumls-concept:C0011923lld:lifeskim
pubmed-article:12230326lifeskim:mentionsumls-concept:C0025936lld:lifeskim
pubmed-article:12230326lifeskim:mentionsumls-concept:C0026018lld:lifeskim
pubmed-article:12230326lifeskim:mentionsumls-concept:C0332461lld:lifeskim
pubmed-article:12230326lifeskim:mentionsumls-concept:C0009742lld:lifeskim
pubmed-article:12230326lifeskim:mentionsumls-concept:C1521801lld:lifeskim
pubmed-article:12230326lifeskim:mentionsumls-concept:C1527240lld:lifeskim
pubmed-article:12230326lifeskim:mentionsumls-concept:C0962722lld:lifeskim
pubmed-article:12230326lifeskim:mentionsumls-concept:C1723136lld:lifeskim
pubmed-article:12230326lifeskim:mentionsumls-concept:C1869507lld:lifeskim
pubmed-article:12230326lifeskim:mentionsumls-concept:C2354310lld:lifeskim
pubmed-article:12230326lifeskim:mentionsumls-concept:C1143503lld:lifeskim
pubmed-article:12230326pubmed:issue9lld:pubmed
pubmed-article:12230326pubmed:dateCreated2002-9-16lld:pubmed
pubmed-article:12230326pubmed:abstractTextThe identification of amyloid deposits in living Alzheimer disease (AD) patients is important for both early diagnosis and for monitoring the efficacy of newly developed anti-amyloid therapies. Methoxy-X04 is a derivative of Congo red and Chrysamine-G that contains no acid groups and is therefore smaller and much more lipophilic than Congo red or Chrysamine-G. Methoxy-X04 retains in vitro binding affinity for amyloid beta (Abeta) fibrils (Ki = 26.8 nM) very similar to that of Chrysamine-G (Ki = 25.3 nM). Methoxy-X04 is fluorescent and stains plaques, tangles, and cerebrovascular amyloid in postmortem sections of AD brain with good specificity. Using multiphoton microscopy to obtain high-resolution (1 microm) fluorescent images from the brains of living PSI/APP mice, individual plaques could be distinguished within 30 to 60 min after a single i.v. injection of 5 to 10 mg/kg methoxy-X04. A single i.p. injection of 10 mg/kg methoxy-X04 also produced high contrast images of plaques and cerebrovascular amyloid in PSI/APP mouse brain. Complementary quantitative studies using tracer doses of carbon- 11-labeled methoxy-X04 show that it enters rat brain in amounts that suggest it is a viable candidate as a positron emission tomography (PET) amyloid-imaging agent for in vivo human studies.lld:pubmed
pubmed-article:12230326pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:languageenglld:pubmed
pubmed-article:12230326pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:citationSubsetIMlld:pubmed
pubmed-article:12230326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12230326pubmed:statusMEDLINElld:pubmed
pubmed-article:12230326pubmed:monthSeplld:pubmed
pubmed-article:12230326pubmed:issn0022-3069lld:pubmed
pubmed-article:12230326pubmed:authorpubmed-author:HymanBradley...lld:pubmed
pubmed-article:12230326pubmed:authorpubmed-author:FroschMatthew...lld:pubmed
pubmed-article:12230326pubmed:authorpubmed-author:MathisChester...lld:pubmed
pubmed-article:12230326pubmed:authorpubmed-author:BacskaiBrian...lld:pubmed
pubmed-article:12230326pubmed:authorpubmed-author:KajdaszStephe...lld:pubmed
pubmed-article:12230326pubmed:authorpubmed-author:McLellanMegan...lld:pubmed
pubmed-article:12230326pubmed:authorpubmed-author:HoltDaniel...lld:pubmed
pubmed-article:12230326pubmed:authorpubmed-author:WangYanmingYlld:pubmed
pubmed-article:12230326pubmed:authorpubmed-author:DebnathManik...lld:pubmed
pubmed-article:12230326pubmed:authorpubmed-author:KlunkWilliam...lld:pubmed
pubmed-article:12230326pubmed:issnTypePrintlld:pubmed
pubmed-article:12230326pubmed:volume61lld:pubmed
pubmed-article:12230326pubmed:ownerNLMlld:pubmed
pubmed-article:12230326pubmed:authorsCompleteYlld:pubmed
pubmed-article:12230326pubmed:pagination797-805lld:pubmed
pubmed-article:12230326pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:meshHeadingpubmed-meshheading:12230326...lld:pubmed
pubmed-article:12230326pubmed:year2002lld:pubmed
pubmed-article:12230326pubmed:articleTitleImaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.lld:pubmed
pubmed-article:12230326pubmed:affiliationDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pennsylvania 15213, USA.lld:pubmed
pubmed-article:12230326pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12230326pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12230326pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12230326lld:pubmed
More...